Zobrazeno 1 - 10
of 106
pro vyhledávání: '"PARTHASARATHI, GURUMURTHY"'
Publikováno v:
Perspectives in Clinical Research, Vol 14, Iss 1, Pp 10-15 (2023)
Purpose: In view of the raising rate of adverse birth outcomes (ABOs) across the globe, this study was conducted to assess the impact of medical conditions and medications received during pregnancy on ABOs. Materials and Methods: A prospective case
Externí odkaz:
https://doaj.org/article/95af2d3922c3425e84cbfca9d3c8176f
Autor:
Rony Abraham Jacob, Priya Srambical Abraham, Feba Rachel Thomas, Vytila Navya, Juny Sebastian, Mandyam Dhati Ravi, Parthasarathi Gurumurthy
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 9 (2021)
Background: India has almost 225 million adolescent girls and they seem to be at a disadvantage, both economically and by their lack of knowledge on human papilloma virus (HPV) vaccine, when compared to adolescent girls of other Asian countries. Aim:
Externí odkaz:
https://doaj.org/article/05d07f3e488d450e9ab48f6a294cf28b
Autor:
Adam M. Fimbo, Omary Mashiku Minzi, Bruno P. Mmbando, Parthasarathi Gurumurthy, Appolinary A. R. Kamuhabwa, Eleni Aklillu
Publikováno v:
Pharmaceuticals, Vol 15, Iss 5, p 594 (2022)
Ivermectin and albendazole (IA) combination preventive chemotherapy to all at-risk populations is deployed to eliminate lymphatic filariasis. Although safety monitoring is imperative, data from Sub-Saharan Africa is scarce. We conducted a large-scale
Externí odkaz:
https://doaj.org/article/fc1c1eadc7d44e289b85b35b7f0938bf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 7 (2019)
Background: Vaccines used in national immunization programs are considered safe and effective but immunization safety has become as important as the efficacy of vaccination programs. The objective of the study was to detect adverse events following i
Externí odkaz:
https://doaj.org/article/bf77328d1b8d4cd1bd28f0d939a84dca
Autor:
Christabel Khaemba, Abbie Barry, Wyckliff P. Omondi, Kefa Bota, Sultani Matendechero, Cecilia Wandera, Fred Siyoi, Elvis Kirui, Margaret Oluka, Pamela Nambwa, Parthasarathi Gurumurthy, Sammy M. Njenga, Anastacia Guantai, Eleni Aklillu
Publikováno v:
Pharmaceuticals, Vol 14, Iss 3, p 264 (2021)
Preventive chemotherapy with diethylcarbamazine citrate (DEC) and albendazole (ALB) is the core intervention strategy to eliminate lymphatic filariasis (LF). We conducted a large-scale prospective active safety surveillance study to identify the inci
Externí odkaz:
https://doaj.org/article/589195115af048178109dadd24e79bf4
Autor:
Tigist Dires Gebreyesus, Tafesse Tadele, Kalkidan Mekete, Abbie Barry, Habtamu Gashaw, Workagegnehu Degefe, Birkneh Tilahun Tadesse, Heran Gerba, Parthasarathi Gurumurthy, Eyasu Makonnen, Eleni Aklillu
Publikováno v:
Pathogens, Vol 9, Iss 11, p 920 (2020)
Preventive chemotherapy (PC) is a WHO-recommended strategy to control and eliminate schistosomiasis and soil-transmitted helminths (STHs). We assessed the prevalence, intensity, and correlates of schistosomiasis and STH infection after five rounds of
Externí odkaz:
https://doaj.org/article/339dd08cbd214c1087423e8ae6bce8fc
Publikováno v:
International Journal of Pharmaceutical Research (09752366). Jan-Mar2021, Vol. 13 Issue 1, p2354-2359. 6p.
Autor:
Tigist Dires Gebreyesus, Eyasu Makonnen, Tafesse Tadele, Habtamu Gashaw, Workagegnew Degefe, Heran Gerba, Birkneh Tilahun Tadesse, Parthasarathi Gurumurthy, Eleni Aklillu
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 21; Pages: 6300
Preventive chemotherapy (PC) with praziquantel and albendazole co-administration to all at-risk populations is the global intervention strategy to eliminate schistosomiasis and soil-transmitted helminth (STH) from being public health problems. Due to
Autor:
Aklillu, Adam M. Fimbo, Omary Mashiku Minzi, Bruno P. Mmbando, Parthasarathi Gurumurthy, Appolinary A. R. Kamuhabwa, Eleni
Publikováno v:
Pharmaceuticals; Volume 15; Issue 5; Pages: 594
Ivermectin and albendazole (IA) combination preventive chemotherapy to all at-risk populations is deployed to eliminate lymphatic filariasis. Although safety monitoring is imperative, data from Sub-Saharan Africa is scarce. We conducted a large-scale